Potential role of miR-9 and miR-223 in recurrent ovarian cancer
about
Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinomaIdentifying microRNA/mRNA dysregulations in ovarian cancerMicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7miRNAs in human cancerA Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to TumorigenesisGenome-wide analysis of microRNA and mRNA expression signatures in cancerThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisThe Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet TherapyMicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancerMicro-RNAs as diagnostic or prognostic markers in human epithelial malignanciesApplication of microRNA in diagnosis and treatment of ovarian cancerEndometriosis and ovarian cancer: links, risks, and challenges facedImpact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological CancerSignature miRNAs involved in the innate immunity of invertebratesRole of miRNA-9 in Brain DevelopmentPrognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysisMicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinomaPre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screeningHigh-throughput sequencing of microRNA transcriptome and expression assay in the sturgeon, Acipenser schrenckiimiRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumorsIdentification of miRNA-mRNA Modules in Colorectal Cancer Using Rough Hypercuboid Based Supervised ClusteringMicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.Network analysis of microRNAs and their regulation in human ovarian cancer.Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.Detection of cancer with serum miRNAs on an oligonucleotide microarray.MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells.Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysisAberrant regulation of FBW7 in cancer.MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells.MicroRNAs in ovarian carcinomasMicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets.MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression.Joint analysis of transcriptional and post- transcriptional brain tumor data: searching for emergent properties of cellular systemsAssociation between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.MiR-223 suppresses cell proliferation by targeting IGF-1R.Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALLStathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.MicroRNAs in human cancer.
P2860
Q21093275-B8367C79-648B-4A2E-A289-B317DB45D535Q21199589-8290517F-E252-416D-88CB-FD82678C6DFCQ24621432-074D463A-0AAE-47D1-91B6-72412ECB3660Q24628889-964B5409-80BF-458C-BE1E-E568C136E17BQ26746952-8C14A3F3-1616-4208-A0F6-DE15B38F7F4EQ26795603-5BA0ADA4-8B4E-4136-8586-07DB3DB83ECAQ26800055-31280BA0-A820-403A-A04E-F26BB6079262Q26801874-C3DA6BD9-A3CA-4BA1-AB72-C40C29D9E0FAQ26822743-6270D173-6AEB-4754-A68D-7F2384367A25Q26823077-ECAE4AF0-D98A-4039-9E56-B30E25CD5333Q26991620-926F02B7-E276-4510-A3FA-39A0EE082833Q27003273-B524327E-8463-49DC-B6EE-684C80F40D72Q27016123-3CBACCC2-4679-42FB-8662-D2E3FA63F35DQ27301064-79471FA0-EEEF-4E75-A95A-13CCB6BACFA1Q28069656-39C25FDF-6655-4DBD-A552-DEE3D72EEC9AQ28079614-85A5D6E3-0F7C-4D87-A3B9-2ED88B53E2E4Q28256145-78B66B49-AEAF-4D4E-AA5D-10E232C6E646Q28289487-320EDDE0-228B-426D-A684-344E212DE6FFQ28394124-EE3DFA0F-0CEA-4BE6-9286-3FAD70D3C94BQ28649789-633C5032-5631-4948-A288-627B76DA66D5Q28742532-1E603917-F26B-4E8F-9F51-4A20F3A639B0Q29248741-C2BA6B20-D208-4F48-A008-4FAABA49B241Q30244282-16E5246E-AB01-475B-9AE8-5930123C5935Q31040165-5696F184-64E1-4165-B4EC-4374EAF5C974Q33275385-1B4E3AA4-42EB-4ACB-A482-5F99F81D4332Q33481633-717FA7A1-2865-46EE-81FE-3604D5868539Q33576848-46D3AB71-31D5-4C1D-85F1-43B8A0B96410Q33618924-4E477648-D5E7-4D30-83DB-8E86CF1633E3Q33688508-0F3AF849-8D16-4F9C-9E59-B475F85DD7AFQ33764106-B6D892FA-14C4-4C4D-BB53-DE060452FDA1Q33796565-A73B2BB3-9B23-4485-A1B1-4461613D1B15Q33815996-7946E1E5-E42F-4B38-8708-D54D913C9640Q33838718-F8527271-3B47-4D48-B0AA-C3E72F2C663BQ33857636-78AB236B-A166-496A-A214-7F4D981B7973Q34029232-AE3BB572-6827-4C99-9FEB-5124EDDF68FAQ34071730-D61B72C9-F0EB-48AD-9892-67F69A5D3EB9Q34197212-9FA28AD4-5133-4DEB-9477-D83C67DC76C7Q34217173-B5D58CBD-2D26-4110-BD75-683DB7B28722Q34217592-C169191F-B6C1-4EC5-8EAF-7D2C472E72E6Q34325959-14C1C38F-528C-49D0-8319-6AC630D96D34
P2860
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@ast
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@en
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@en-gb
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@nl
type
label
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@ast
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@en
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@en-gb
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@nl
prefLabel
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@ast
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@en
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@en-gb
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
@en
P2093
Brian Sheppard
Cara Martin
Ciara Barrett
Eamonn McGuinness
John O' Leary
Martina Ring
Massimo Loda
Noreen Gleeson
Sharon O'Toole
Tom D'Arcy
P2860
P2888
P3181
P356
10.1186/1476-4598-7-35
P407
P577
2008-04-28T00:00:00Z
P5875
P6179
1040226229